Drugplain

ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 68 mg/g

OCTINOXATE, TITANIUM DIOXIDE AND ZINC OXIDE · GEL · ESTEE LAUDER INC

No Recall History
Plain English

ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 is a gel containing octinoxate, titanium dioxide and zinc oxide at 68 mg/g, taken topical. Manufactured by ESTEE LAUDER INC.

Key Facts

Brand Name
ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36
Generic Name
OCTINOXATE, TITANIUM DIOXIDE AND ZINC OXIDE
NDC Code (Product)
11559-062
Manufacturer
ESTEE LAUDER INC
Strength
68 mg/g
Dosage Form
GEL
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
07/07/2021

Recall History

No Recall History

Frequently Asked Questions

What is ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 used for?

ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 contains OCTINOXATE, TITANIUM DIOXIDE AND ZINC OXIDE. It is a gel taken topical. Consult your doctor for specific uses.

Is ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 a controlled substance?

ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 is not classified as a controlled substance by the DEA.

What is the generic name for ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36?

The generic name for ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 is OCTINOXATE, TITANIUM DIOXIDE AND ZINC OXIDE. There are 1 other brand versions of OCTINOXATE, TITANIUM DIOXIDE AND ZINC OXIDE.

What is the NDC code for ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 68 mg/g?

The NDC (National Drug Code) for ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 68 mg/g is 11559-062, listed by ESTEE LAUDER INC.

Product NDC

11559-062

Package NDC

11559-062-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)